Literature DB >> 30479469

Phenotypic Features of Central Sensitization.

David A Williams1.   

Abstract

PURPOSE: The current manuscript reviews approaches for phenotyping central sensitization (CS).
METHODS: The manuscript covers the concept of diagnostic phenotyping, use of endophenotypes, biomarkers, and symptom clusters. Specifically, the components of CS that include general sensory sensitivity (assessed by quantitative sensory testing) and a symptom cluster denoting sleep difficulties, pain, affect, cognitive difficulties, and low energy (S.P.A.C.E.).
RESULTS: Each of the assessment domains are described with reference to CS and their presence in chronic overlapping pain conditions (COPCs) - conditions likely influenced by CS.
CONCLUSIONS: COPCs likely represent clinical diagnostic phenotypes of CS. Components of CS can also be assessed using QST or self-report instruments designed to assess single elements of CS or more general composite indices.

Entities:  

Keywords:  Central Sensitization; Chronic Overlapping Pain Conditions (COPCs); Mental Load; Phenotyping; Sensory Hypersensitivity; Unwellness

Year:  2018        PMID: 30479469      PMCID: PMC6251410          DOI: 10.1111/jabr.12135

Source DB:  PubMed          Journal:  J Appl Biobehav Res        ISSN: 1071-2089


  104 in total

Review 1.  Symptom clusters: myth or reality?

Authors:  Aynur Aktas; Declan Walsh; Lisa Rybicki
Journal:  Palliat Med       Date:  2010-06       Impact factor: 4.762

2.  Towards an integrative picture of human sickness behavior.

Authors:  Eric C Shattuck; Michael P Muehlenbein
Journal:  Brain Behav Immun       Date:  2016-05-07       Impact factor: 7.217

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

4.  A global measure of perceived stress.

Authors:  S Cohen; T Kamarck; R Mermelstein
Journal:  J Health Soc Behav       Date:  1983-12

5.  Fatigue in fibromyalgia: a conceptual model informed by patient interviews.

Authors:  Louise Humphrey; Rob Arbuckle; Philip Mease; David A Williams; Bente Danneskiold Samsoe; Claire Gilbert
Journal:  BMC Musculoskelet Disord       Date:  2010-09-20       Impact factor: 2.362

6.  Association of Fine Motor Loss and Allodynia in Fibromyalgia: An fNIRS Study.

Authors:  Aykut Eken; Didem Gökçay; Cemre Yılmaz; Bora Baskak; Ayşegül Baltacı; Murat Kara
Journal:  J Mot Behav       Date:  2017-12-06       Impact factor: 1.328

Review 7.  Symptom clusters: the new frontier in symptom management research.

Authors:  Christine Miaskowski; Marylin Dodd; Kathryn Lee
Journal:  J Natl Cancer Inst Monogr       Date:  2004

Review 8.  Disclosure of traumas and psychosomatic processes.

Authors:  J W Pennebaker; J R Susman
Journal:  Soc Sci Med       Date:  1988       Impact factor: 4.634

9.  The PROMIS FatigueFM Profile: a self-report measure of fatigue for use in fibromyalgia.

Authors:  Anna L Kratz; Stephen Schilling; Jenna Goesling; David A Williams
Journal:  Qual Life Res       Date:  2016-01-28       Impact factor: 4.147

10.  Stress-induced allodynia--evidence of increased pain sensitivity in healthy humans and patients with chronic pain after experimentally induced psychosocial stress.

Authors:  Benjamin Crettaz; Martin Marziniak; Peter Willeke; Peter Young; Dirk Hellhammer; Astrid Stumpf; Markus Burgmer
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

View more
  27 in total

Review 1.  Emotional Awareness and Expression Therapy for Chronic Pain: Rationale, Principles and Techniques, Evidence, and Critical Review.

Authors:  Mark A Lumley; Howard Schubiner
Journal:  Curr Rheumatol Rep       Date:  2019-05-23       Impact factor: 4.592

Review 2.  Psychological Therapy for Centralized Pain: An Integrative Assessment and Treatment Model.

Authors:  Mark A Lumley; Howard Schubiner
Journal:  Psychosom Med       Date:  2019 Feb/Mar       Impact factor: 4.312

3.  Adaptive body awareness predicts fewer central sensitization-related symptoms and explains relationship between central sensitization-related symptoms and pain intensity: A cross-sectional study among individuals with chronic pain.

Authors:  Dana Dharmakaya Colgan; Ashley Eddy; Kaylie Green; Barry Oken
Journal:  Pain Pract       Date:  2021-11-11       Impact factor: 3.183

4.  The pros and cons of tDCS as a therapeutic tool in the rehabilitation of chronic pain.

Authors:  J S Ho; E Slawka; K Pacheco-Barrios; A Cardenas-Rojas; L Castelo-Branco; F Fregni
Journal:  Princ Pract Clin Res       Date:  2022-07-03

Review 5.  Approach to Diagnosis and Management of Chronic Pelvic Pain in Women: Incorporating Chronic Overlapping Pain Conditions in Assessment and Management.

Authors:  Sara R Till; Reina Nakamura; Andrew Schrepf; Sawsan As-Sanie
Journal:  Obstet Gynecol Clin North Am       Date:  2022-06       Impact factor: 2.838

6.  Electronic Delivery of Pain Education for Chronic Overlapping Pain Conditions: A Prospective Cohort Study.

Authors:  Lindsey C McKernan; Leslie J Crofford; Ahra Kim; Simon N Vandekar; William S Reynolds; Kathryn A Hansen; Daniel J Clauw; David A Williams
Journal:  Pain Med       Date:  2021-10-08       Impact factor: 3.750

7.  Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey.

Authors:  Kevin F Boehnke; Joel J Gagnier; Lynne Matallana; David A Williams
Journal:  J Pain       Date:  2021-05-13       Impact factor: 5.820

8.  Neurobiological antecedents of multisite pain in children.

Authors:  Chelsea M Kaplan; Andrew Schrepf; Ishtiaq Mawla; Eric Ichesco; Kevin F Boehnke; Adriene Beltz; Emily Foxen-Craft; Michael P Puglia; Alexandre Tsodikov; David A Williams; Afton L Hassett; Daniel J Clauw; Steven E Harte; Richard E Harris
Journal:  Pain       Date:  2022-04-01       Impact factor: 7.926

9.  Chronic pain following spinal cord injury: Current approaches to cellular and molecular mechanisms.

Authors:  Jessica R Yasko; Richard E Mains
Journal:  Trends Cell Mol Biol       Date:  2018

10.  Cannabidiol Product Dosing and Decision-Making in a National Survey of Individuals with Fibromyalgia.

Authors:  Kevin F Boehnke; Joel J Gagnier; Lynne Matallana; David A Williams
Journal:  J Pain       Date:  2021-06-30       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.